Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on June 9, 2026

Jun. 9, 2026

Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy

Indeterminate GlobeNewswire

Jun. 9, 2026

Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle

Indeterminate GlobeNewswire

Jun. 9, 2026

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine…

Indeterminate GlobeNewswire

Jun. 9, 2026

MitoRx Therapeutics Strengthens Leadership Team with C-Suite and Board Appointments to Support Next Phase of Growth

Indeterminate GlobeNewswire

Jun. 9, 2026

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 9, 2026

DBV Technologies révise sa participation à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs

Indeterminate GlobeNewswire

Jun. 9, 2026

Antag Therapeutics Elects Keith Leonard as Chairman of its Board of Directors

Indeterminate GlobeNewswire

Jun. 9, 2026

Atavistik Bio Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation for ATV-1601 for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire

Jun. 9, 2026

NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University

Indeterminate GlobeNewswire

Jun. 9, 2026

BioStem Technologies Announces Appointment of Three New Members to its Board of Directors

Indeterminate GlobeNewswire

Jun. 9, 2026

Apollo Therapeutics Appoints Timothy P. Walbert as Chairman of the Board

Indeterminate GlobeNewswire

Jun. 9, 2026

NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026

Indeterminate GlobeNewswire

Jun. 9, 2026

Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases

Indeterminate GlobeNewswire

Jun. 9, 2026

BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board

Indeterminate GlobeNewswire

Jun. 9, 2026

Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration

Indeterminate GlobeNewswire

Jun. 9, 2026

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Indeterminate GlobeNewswire

Jun. 9, 2026

Bavarian Nordic modtager ny ordre fra regering på koppe-/mpoxvacciner

Indeterminate GlobeNewswire

Jun. 9, 2026

Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine

Indeterminate GlobeNewswire

Jun. 9, 2026

Burning Rock Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jun. 9, 2026

Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies

Indeterminate GlobeNewswire